Lantheus Holdings (LNTH) Asset Utilization Ratio (2015 - 2026)
Lantheus Holdings (LNTH) posted quarterly Asset Utilization Ratio of 0.68 for Q1 2026, down 11.23% year-over-year from 0.76 in Q1 2025, and down 1.24% quarter-over-quarter from 0.68 in Q4 2025.
Lantheus Holdings (LNTH) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Asset Utilization Ratio for 12 consecutive years, with 0.68 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 11.23% year-over-year to 0.68; the TTM figure through Mar 2026 stood at 0.68 (down 11.23% YoY), while the FY2025 annual figure was 0.73, down 13.26% from the prior year.
- Asset Utilization Ratio declined to 0.68 in Q1 2026 per LNTH's latest filing, from 0.68 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.84 in Q3 2023 and bottomed at 0.58 in Q3 2024.
- Historically, Asset Utilization Ratio has averaged 0.7 across 5 years, with a median of 0.69 in 2025.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio surged 66.22% — and 2024, when it sank 31.17%.
- Lantheus Holdings' Asset Utilization Ratio stood at 0.77 in 2022, then retreated by 21.99% to 0.6 in 2023, then increased by 26.13% to 0.76 in 2024, then slipped by 10.07% to 0.68 in 2025, then retreated by 1.24% to 0.68 in 2026.
- Business Quant data shows LNTH's Asset Utilization Ratio at 0.68 in Q1 2026, 0.68 in Q4 2025, and 0.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.65 |
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.68 |
| Sep 30, 2025 | 0.69 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.76 |
| Dec 31, 2024 | 0.76 |
| Sep 30, 2024 | 0.58 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.84 |
| Jun 30, 2023 | 0.84 |
| Mar 31, 2023 | 0.77 |
| Dec 31, 2022 | 0.77 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 0.68 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 0.50 |
| Sep 30, 2021 | 0.46 |